Passage Bio Inc (PASG) — Financial Flexibility Index
Passage Bio Inc (PASG) has a Financial Flexibility Index of -0.11x as of September 2025. Free cash flow of $-4.85 Million (operating CF $-4.85 Million minus capex $0.00) represents 0% of total liabilities ($43.04 Million). Check PASG strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Passage Bio Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Passage Bio Inc across 7 annual periods. See PASG current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Passage Bio Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Passage Bio Inc. For the full company profile including market capitalisation, see market cap of Passage Bio Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.16x | $-47.92 Million | $-47.96 Million | $41.15 Million | ▲ +41.5% |
| 2023 | -1.99x | $-78.12 Million | $-78.26 Million | $39.26 Million | ▲ +25.7% |
| 2022 | -2.68x | $-112.94 Million | $-118.21 Million | $42.18 Million | ▲ +3.7% |
| 2021 | -2.78x | $-101.24 Million | $-126.88 Million | $36.42 Million | ▲ +17.9% |
| 2020 | -3.39x | $-78.87 Million | $-80.52 Million | $23.29 Million | ▲ +62.2% |
| 2019 | -8.97x | $-38.20 Million | $-39.90 Million | $4.26 Million | ▼ -2453.3% |
| 2018 | -0.35x | $-16.02 Million | $-18.57 Million | $45.63 Million | — |